INGRID MINOR: Open Payments
NPI 1841248507 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,290 in 140 payments from 23 companies in 2025. Trend: 2023 $2,538 · 2024 $2,736 · 2025 $2,290
Food & beverage: $2,206Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $440 |
| UCB, Inc. | 19 | $373 |
| Neurelis, Inc. | 12 | $205 |
| Lundbeck LLC | 10 | $173 |
| Janssen Biotech, Inc. | 3 | $134 |
| Neurocrine BioSciences, Inc. | 5 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
Products named: Rystiggo, VALTOCO, QULIPTA, UBRELVY, REXULTI, INGREZZA, VYEPTI, Kerendia.
Industry payments across KY — which companies pay providers there.
